|
2006P-0520:
ANDA for Methotrexate Injection, USP, Preservative Free, Eq. 500
mg base/20 mL (25 mg/mL)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| ACK1
|
| 12/18/2006
|
| 12/18/2006
|
| Drug Industry
|
| FDA/DDM to SICOR Pharmaceuticals,
Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Jennie Butler
|
|
|
|
|
| CP1
|
| 12/18/2006
|
| 12/18/2006
|
| Drug Industry
|
| SICOR Pharmaceuticals,
Inc.
|
|
|
|
|
|
|
| Table
of Contents
|
|
|
|
|
| Signature:
|
| Tania Hoffman
|
|
|
|
|
| EC1
|
| 01/05/2007
|
| 01/04/2007
|
| Individual Consumer
|
| Mr. Dave Lowe
|
|
|
|
|
|
|
| htm
Attachment
|
|
|
|
|
|
|
|
Top
| Up
Page last updated:
January 26, 2007
|
